Polymerase Chain Reaction Market, By Type (Conventional PCR, Others), By Product (Consumables & Reag

Published Date: | Report Code : CH2068948


Polymerase Chain Reaction Market, By Type (Conventional PCR, Others), By Product (Consumables & Reagents, Instruments, and Software & Services), By Application [Medical {Clinical (Pathogen Testing, Oncology testing, Blood Screening, and Others), Research, Forensic, and others}, Non-Medical {Food, and Others}], and By Region (North America, Europe, Asia Pacific, Middle East and Africa, and South America)–Market Size & Forecasting To 2028

COVID-19 Impact : Our team has been closely monitoring the current developments to identify the potential impact of COVID-19 on stakeholders and business processes across the value chain of industries. A special section about COVID-19 will be covered with the report to help companies in defining sustainable strategies.

Domain : Chemicals

Report Code : CH2068948

Status : Upcoming

The global polymerase chain reaction market is expected to attain a value of USD XX million by 2028, at a CAGR of XX from USD XX million in 2019. The key factors that are propelling the growth of the market for polymerase chain reaction include the growing demand for advanced diagnostic techniques, prenatal genetic testing procedures, rising prevalence of CROs (Clinical Research Organization) and forensic & research laboratories due to its accuracy, precision, real-time quantification, automation, and sensitivity.

Medical devices that are used to produce millions of copies of a part of deoxyribonucleic acid (DNA) are known as polymerase chain reaction technologies. In various fields of life sciences, such as genetics, molecular biology studies, biotechnology, drug discovery, and clinical diagnostics, these instruments are widely used.

In addition, these technologies are used in the forensic department to identify suspects and also for child identification. The system may also be used in the diagnosis and treatment of diseases such as tuberculosis, middle ear infections, AIDS, and Lyme diseases. Polymerase chain reaction techniques are also used in the academic field to classify communities of microorganisms causing diseases.

Increased support in the form of government funding to perform genomics-based research is expected to drive market growth. For example, Genomics Medicine Ireland (GMI) obtained a funding of USD 413.91 million for performing genomics research in Ireland in 2018. This has enabled researchers to scale up to more than 60 areas of diseases to reduce or eliminate the disease effect.

In addition, it is expected that the introduction of new technologies to improve companies’ portfolios and provide consumers with innovations would propel market growth in the near future. For instance, Thermo Fisher Scientific, Inc. released the world first smart qPCR tools in April 2019: The real-time PCR systems of Applied Biosystems QuantStudio 6 and 7 Pro are built to provide a smart workflow interface that brings lab-changing qPCR innovations for research.

Impact of Covid-19

Healthcare professionals have their hands full at present with the number of coronavirus cases rising exponentially every day and with no vaccine or drug on the horizon. The demand for testing kits has risen in the wake of such increasingly rising cases. PCR remains the most prevalent of all research mechanisms currently employed. To detect the presence of the virus and to assess the degree of infection inside the patient, this test is commonly used.

The RT-PCR approach is highly popular among medical professionals to detect COVID-19 cases due to its high degree of accuracy and precision of testing data. Usually, the procedure takes 4 to 8 hours, while the findings are delivered almost 24 hours after the test has been carried out. Due to this time lag, healthcare domains are trying to find alternate testing methods capable of producing the findings in a shorter period of time.

Nevertheless, it is expected that the RT-PCR test will witness a surge in the upward direction till the effect of covid-19 increases. In addition, to allow unlimited access to quick and stable COVID-19 testing, home testing kits have been rolled out.

The polymerase chain reaction market is segmented on the basis of type, product, and application.

Based on type, the market is divided into conventional PCR and others. The others segment held the largest share of the market in 2019, and it is expected to continue to do so during the forecast period as well. Real time PCR (qPCR), multiplex, digital PCR (dPCR), and ultrafast PCR are other types of Polymerase chain reaction. The growing adoption of qPCR and dPCR due to their rapid identification of pathogens and infections, as opposed to general technologies, is among the contributing factors responsible for the prominence of this segment.

Higher sensitivity and resolution, the potential for automation, and the high usage of genetic analysis and genotyping as a validation method are other factors that are favoring this segment’s growth. Furthermore, it is anticipated that the production and introduction of new technologies in this segment would drive its growth in the coming years. This involves plasmonic PCR, a low-cost approach that can more easily detect infections and pathogens than the conventional PCR technologies.

Based on the product, the market has been divided in consumables & reagents, instruments, and software & services. Among these, the Consumables & Reagents segment held the largest market share in 2019, and it is poised to dominate the market during the forecast period as well. This is because of the significant demand for genetic screening in nations across the globe with unmet health needs and the availability of technically advanced diagnostic tests. Furthermore, the development of new products is likely to lead the segment’s growth. However, during the forecast period, the software & services segment is expected to grow with the highest CAGR during the forecast period.

By application, the market is segmented into medical and non-medical. Among these, the medical segment was estimated to hold the largest market share in 2019 and is expected to dominate the market during the forecast period. This growth is attributed to its benefits in research as well as other applications, such as the identification and quantification of low-frequency mutations and low levels of higher sensitivity pathogens.

Moreover, increasing PCR acceptance in diagnostic medical centers is expected to propel the market growth. The medical segment is divided into clinical, research, and forensic and other. In addition, based on the clinical segment, the market is further segmented into pathogen testing, oncology testing, blood screening, and others.

Regional Outlook:

Region-wise, the worldwide polymerase chain reaction market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is predicted to hold a dominant position, while Asia Pacific is anticipated to grow with the highest CAGR during the forecast period. In North America, favorable government policies, coupled with flexible government regulations, are expected to propel the regional market. In February 2020, for example, the Department of Health and Human Services has declared the approval of the emergency use of diagnostics for COVID-19 identification. This authorization has increased the number of product launches for diagnostics in the country.

Competitive Landscape

The competitive scenario highlights the performance of major companies operating in the polymerase chain reaction market. This includes the detailed profiling of major companies and their competitive benchmarking. Product profiling provides key information including products/solutions offered, key developments, company performances, and strategies adopted in recent years.

The major companies profiled in the market include Thermo Fisher Scientific Inc.; Bio-Rad Laboratories, Inc.; QIAGEN; F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Cepheid, Agilent Technologies, Inc.;  SA; GE Healthcare; Stilla; Microsynth AG; JN Medsys; and Fluidigm Corporation, among others. Additionally, the competitive landscape provides a detailed description of each company including future capacities, financial overview, key mergers & acquisitions, partnerships, collaborations, new product developments, new product launches, and other latest industrial developments.

What Does This Report Provide?

This report provides a detailed understanding of the global polymerase chain reaction market from qualitative and quantitative perspectives during the forecast period. The report also provides dynamic indicators with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the market.

Market Segmentation:

By Type

  • Conventional PCR
  • Others

By Product

  • Consumables & Reagents
  • Instruments
  • Software & Services

By Application

  • Medical
  • Clinical
  • Pathogen Testing
  • Oncology testing
  • Blood Screening
  • Others
  • Research
  • Forensic and others
  • Non-Medical
  • Food
  • Others

By Region:

  • North America
    • By Country (US, Canada, Mexico)
    • By Type
    • By Product
    • By Application
  • Europe
    • By Country (Russia, Germany, UK, France, Italy, Spain, Rest of Europe)
    • By Type
    • By Product
    • By Application
  • Asia Pacific
    • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
    • By Type
    • By Product
    • By Application
  • Middle East and Africa
    • By Country (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East and Africa)
    • By Type
    • By Product
    • By Application
  • South America
    • By Country (Argentina, Brazil, Rest of South America)
    • By Type
    • By Product
    • By Application

Reasons to Buy This Report:

  • Market size estimation of the polymerase chain reaction market on a regional and global basis
  • Unique research usage for market size estimation and forecasts
  • Profiling of major companies operating in the market with key developments
  • Broad scope to cover all the possible segments, helping every stakeholder in the market


We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

For more information, contact: [email protected]

License Offering

Single User (PDF)


Multi User (PDF)


Enterprise User (PDF)


Get Regional Report @ USD 2000 Only

Your personal details are secure. Privacy Policy

Buy Chapters of Sections

Avail customized purchase options to meet your exact research needs.

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision


Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

15% Free Customization

Share your Requirements

Questions?  Speak to an Analyst

Your personal details are secure. Privacy Policy